| __timestamp | TG Therapeutics, Inc. | Verona Pharma plc |
|---|---|---|
| Wednesday, January 1, 2014 | 31354781 | 4101058 |
| Thursday, January 1, 2015 | 43445817 | 10763215 |
| Friday, January 1, 2016 | 66489820 | 5579049 |
| Sunday, January 1, 2017 | 96886134 | 32051299 |
| Monday, January 1, 2018 | 153793000 | 24482286 |
| Tuesday, January 1, 2019 | 148369000 | 43892589 |
| Wednesday, January 1, 2020 | 151934000 | 44505000 |
| Friday, January 1, 2021 | 198532000 | 79406000 |
| Saturday, January 1, 2022 | 112128000 | 49283000 |
| Sunday, January 1, 2023 | 76192000 | 17282730 |
Unleashing insights
In the ever-evolving landscape of biotechnology, research and development (R&D) spending is a critical indicator of a company's commitment to innovation. Over the past decade, TG Therapeutics, Inc. and Verona Pharma plc have demonstrated contrasting approaches to R&D investment.
From 2014 to 2023, TG Therapeutics consistently outpaced Verona Pharma in R&D expenditure, peaking in 2021 with a 98% increase from their 2014 spending. This robust investment underscores their aggressive pursuit of novel therapies. In contrast, Verona Pharma's R&D spending, while more modest, saw a significant 1,840% increase from 2014 to 2021, reflecting a strategic scaling of their research efforts.
These trends highlight the diverse strategies within the biotech sector, where both high and steady growth in R&D can drive innovation and potentially lead to groundbreaking medical advancements.
AstraZeneca PLC vs Verona Pharma plc: Strategic Focus on R&D Spending
R&D Spending Showdown: Vertex Pharmaceuticals Incorporated vs Verona Pharma plc
Takeda Pharmaceutical Company Limited or Verona Pharma plc: Who Invests More in Innovation?
R&D Spending Showdown: Bio-Techne Corporation vs Verona Pharma plc
Research and Development: Comparing Key Metrics for Ascendis Pharma A/S and TG Therapeutics, Inc.
Analyzing R&D Budgets: Madrigal Pharmaceuticals, Inc. vs Verona Pharma plc
Who Prioritizes Innovation? R&D Spending Compared for TG Therapeutics, Inc. and Viking Therapeutics, Inc.
Research and Development Investment: Verona Pharma plc vs CymaBay Therapeutics, Inc.
Research and Development: Comparing Key Metrics for Verona Pharma plc and Apellis Pharmaceuticals, Inc.
Research and Development Expenses Breakdown: Verona Pharma plc vs Amphastar Pharmaceuticals, Inc.
R&D Insights: How Verona Pharma plc and MannKind Corporation Allocate Funds
Analyzing R&D Budgets: Verona Pharma plc vs Galapagos NV